SKI Market

Indian Indices

Nifty

25,637.80 88.80
(0.35%)

Sensex

83,753.22 -305.68
( -0.36%)

Bank Nifty

57,443.90 237.20
( 0.41%)

Nifty IT

38,822.95 -173.30
( -0.44%)

Global Indices

Nasdaq

43,834.06 426.21
(0.98%)

Dow Jones

6,192.89 30.87
(0.50%)

Hang Seng

40,056.27 471.69
(1.19%)

Nikkei 225

8,798.91 63.31
(0.72%)

Forex

USD-INR

85.73 -0.26
(-0.30%)

EUR-INR

100.32 0.36
(0.36%)

GBP-INR

117.66 0.46
(0.39%)

JPY-INR

0.59 0.00
(0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Enbee Trade & Finance Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

512441

INE993I01029

1.3878134

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

8.33

42.88

EPS(TTM)

Face Value()

Div & Yield %

0.09

Back

J B Chemicals & Pharmaceuticals receives USFDA approval for Amitriptyline Hydrochloride Tablets

Jun 26,2025

J B Chemicals & Pharmaceuticals has received approval from United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA), Amitriptyline Hydrochloride Tablets USP, 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, and 150 mg, which is indicated for relief of symptoms of depression.

25,637.80 88.80 (0.35%)

83,753.22 -305.68 ( -0.36%)

57,443.90 237.20 ( 0.41%)

38,822.95 -173.30 ( -0.44%)

43,834.06 426.21 (0.98%)

6,192.89 30.87 (0.50%)

40,056.27 471.69 (1.19%)

8,798.91 63.31 (0.72%)

85.73 -0.26 (-0.30%)

100.32 0.36 (0.36%)

117.66 0.46 (0.39%)

0.59 0.00 (0.31%)